chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lost sense of taste, extreme fatigue, left arm pain and breast pain on left side. Mammogram showed no masses. I continued to not feel well and fatigued. On 3/28/21 started to feel eye discomfort and left eye started to swell. By the end of 3/29/21 left eye was swollen shut and face was burning and head felt hot. Went to urgent care  and was given antibiotics. Went to emergency care that same night and was hospitalized and given various antibiotics. I had swelling in my head and was released on 4/2/21. The hot head and head pain and dizinness has continued and no one has an explanation for this except vestibular migraines. I ended up with a second eye infection and given another round of antibiotics and Diagnosed with Cellulitis, but doctors have had no explanation and reason as to why this is happening.
Per mother that same night she had a mild rash but the rash has now spread to thighs, legs, arms and face. Patient prescribed: Benadryl Allergy Childrens Liquid, 12.5 MG/5ML, 6 ml as needed, Orally, every 8 hrs, 5 days, 120 ml Hydrocortisone Cream, 2.5 %, 1 application to affected area, Externally, Twice a day, 5 days, 30 Referral To: Allergy and Immunology TCH Allergy and Immunology Pediatric Allergist Reason:Allergic reaction after Hepatits A vaccine. Please evaluate. Patient's allergy got better after allergy medication.
Became short of breath on both Saturday and Sunday.  On Monday, 11/24/2014, blacked-out and fell.  Sent to hospital by ambulance where it was eventually determined that I had Right Bundle Branch Block, and a Pacemaker was installed.
After 3 days of flu like symptoms and fever 101F,  fatigue, fogginess, and apric if low grade fever 99.100.2F occurring in the evenings between 6:30 pm and 11 pm associated with flu like symptoms. These occur every two to three weeks and last 7-10 days but only 2-3 days I et the past month. About three months ago, multiple joint pains especially in the hips, knees, lower back, elbows, metacarpophalangeal joint preventin comfortable driving  making fists or mild muscular efforts pulling bed sheets etc.. these were also associated with moderately severe stiffness in the thighs, calves and shoulders, exagération of double vision and squinting of the et eye. Stiffness would improve after  2 min sof slow walking but with weakness and fatigue progressing to shuffling gate after 20-30 min. Also itching all over with no rash over the past m?ont inflammation of the right nipple with burning sensation swelling redness and itching also hypersensitivity. Mental fogginess and exhaustion after 20-30 min of physical activity. Ployuria for 2 months . Parosmia with spoiled food odor, industrial dust or a dead animal, loss of appetite.in September marked dyspnea ER CT scan ruled out pneumonia and Covid antigen test were negative  Recovered from polyuria, joints partially improved.
At 0300 (15 hrs after 2nd shot) woke with chills. Slept under 3 blankets -usually use only one.    Chills mostly over by 0700. Still feel fatigued. Slight tenderness on arm of injection site.
Mom stated child cried 4-5 hours after having PENTACEL. Notified provider prior to next scheduled dose. Next dose not given of PENTACEL. Only HIB :IPV given 0 DTAP.
fatigue, headache, muscle pain, joint pain, chills, fever, loss of appetite leading to dehydration
some complications she experienced when she took the vaccine for COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (002591). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION COMPLICATION (non-serious), outcome "unknown", described as "some complications she experienced when she took the vaccine for COVID".   Additional information: Patient indicated that she had to stop taking her Xeljanz medication due to some complications she experienced when she took the vaccine for COVID. Patient was prescribed Xeljanz XR 11mg.  Follow-up attempts completed. No further information is expected.
This spontaneous report as received from a consumer refers to his/her friend who was a 75 year old female patient who enrolled in ZOSTAVAX Testing program (the reporter was also reported as the patient herself). On an unknown date the patient was vaccinated with ZOSTAVAX (lot#, dose, frequency and route unknown). On unknown dates the patient developed shingles twice after receiving shingles vaccination. The outcome of the event was reported as recovered/resolved with sequelae. The reporter considered the event to be serious due to hospitalization/prolonged. Additional information is not expected as the reporter is not willing of follow up contact.
A non-serious spontaneous report of expired dose of FLUMIST given was received from a health professional concerning a seven-year-old male patient. Neither relevant medical history nor concomitant medications have been reported for this patient. The vaccine expired on 09-Jan-2011. The patient received the expired FLUMIST on 18-Jan-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 05-Apr-2011 which confirmed that the patient did not experience any adverse events following administration of expired FLUMIST. This information was incorporated into the narrative.
Information has been received form a consumer concerning his son in law who on unspecified date was vaccinated with a dose of ZOSTAVAX. Five days after receiving ZOSTAVAX the patient experienced a severe case of shingles around his waist. This is one of two reports from the same source. Additional information is not expected.
tingling sensation in his left pinky, tingling sensation on his tongue that comes and goes, feeling dizzy, didn't eat anything since 7:30/8am, dry mouth, there was no injection site swelling, patient still able to sense  pressure/touches on his arm
Heart burn; Abdominal pain; This is a spontaneous report from a contactable consumer (patient). A 17-year-old non- pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration at age of 17 years on 27Sep2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. No covid prior vaccination. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at age of 17 years on 09Sep2021 for COVID-19 Immunization. The patient experienced heart burn, abdominal pain, and more (as reported) in 2021. The events resulted in emergency room/department or urgent care and received treatment of antibiotics, blood work, pain medicine (in 2021). Covid test post vaccination was PCR via nasal swab on 27Sep2021 and negative. The outcome of the events was unknown.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Woke up around 5:30AM having to go to the bathroom.  Went to Flush the toilet and passed out on the floor.  My wife found me unresponsive but breathing on the floor.  My wife called 911 and was at the hospital around 6:15AM.
Woke up with chest pain; He said his upper back was aching; temperature of 100 degree; Sinus pain; Sinus pain and Congestion; This is a spontaneous report from a contactable consumer. A 15-year-old male patient received second dose of BNT162B2 (Pfizer Covid-19 vaccine; Solution for injection; Batch/Lot Number: EW0185) intramuscular, administered in Arm Right on 04Jun2021 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (Batch/Lot Number: EW0182) on right upper arm on 14May2021 for covid-19 immunisation. The patient reported, had his 2nd vaccine on Friday 2 days ago yesterday he just had congestion, today on 06Jun2021, he woke up with chest pain and he said his upper back was aching and he has chest pain. He is also having temperature of 100 degree, so Tylenol was given. Sinus congestion and pain was yesterday on 05Jun2021. He does not have congestion today. Yesterday for sinus pain and congestion, the patient was given Sudafed 1 tablet. It is an over-the-counter medicine, 30 milligrams 1 tablet. A history of sinus was reported for about everybody in his family got sinus one time in life. The outcome for the events sinus congestion and pain was recovered on 06Jun2021. Outcome for the events chest pain, upper back was aching and having temperature of 100 degree was unknown.
Client reported being bothered by 'blurry vision' about 25 minutes after receiving  the Moderna vaccine, accompanied by feeling dizzy and lightheaded.  Speech was normal, grip strength equal and strong.  Blood pressure was low (85/58), HR 94.  Client drank 12 oz water over 5 minutes, BP improved to 95/60 w/ HR 86 (11:48).  Client still c/o blurry vision and light headedness, but was talkative and making jokes.  He started to stand (to test his balance) but was still unsteady. Gave him another bottle of water, explaining re: low BP and hydration.  Reassessed after an additional 5 minutes (11:53) with BP further improved to 100/62.  Denied improvement in vision or lightheadedness.  Client sat for 30 more minutes.  I attended to another client at 12:00, with another RN monitoring him.  When I returned to check on him, she said he did not exhibit any signs of being in distress and got up to leave voluntarily.
Pain and tingling on the left side extending to toes, tingling continued for over a week, a lot of pain in shoulder has been continuous until now. Arm feels "dead." Missed work for several days, fainted at work 3 days after. Pain has felt to decrease over time, but came back last night.
3cm area of erthyma @ inject site; Temp 103F, listless;
one month after receiving the booster dose; he had cellullitis; suffered terrible joint pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from information team.  A 79 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: CELLULITIS (medically significant), outcome "unknown", described as "he had cellullitis"; IMMUNISATION (non-serious), outcome "unknown", described as "one month after receiving the booster dose"; ARTHRALGIA (non-serious), outcome "unknown", described as "suffered terrible joint pain". Clinical Course: Reporter's husband also suffered terrible joint pain about one month after receiving the booster dose and found out the next morning that he had cellulitis. They both had the same lot number of the vaccine. It was reported that side effects are usually reported within 7 days of application of the vaccine and in the follow up of one month after the booster dose there were no reports of joint pain.   The lot number for bnt162b2 was not provided and will be requested during follow up.
A report has been received from a Health Professional concerning a pregnant patient who was in the second trimester. The patient received nasal FLUMIST Quadrivalent.  FLUMIST Quadrivalent started on an unknown date. A pregnant woman was administered with FLUMIST Quadrivalent. The outcome of the event of pregnant woman was administered FLUMIST Quadrivalent was unknown. The report was considered to be non-serious by the reporter.
On 5/11/01, mother noted bruising, small purpuric lesions of legs, trunk and face. Pt was admitted to a hospital for 2 days. Given IV therapy.  diagnosed with thrombocytopenia and pancytopenia
Alopecia areata of note at base of skull and left temporal area since 6/20/13, labs WNL, dermatologist involved in care.
pt recv vax 21JUN95 & 18JUL95 pt exp a change in mental status & was confused;An ER MD was required to treat these adverse events;pt was hospitalized;an MRI revealed white matter changes;
This initial spontaneous case, received on 31-Oct-2017, reported by other non-health professional concerns a 50-year-old, adult, female patient. Patient's medical history and concomitant medications were not reported. On 26-Oct-2017, the patient received, FLUCELVAX QIV (dose: 0.5 ml, route administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On the same day, after a couple of hours of vaccination, the patient had pain in her arm and was not able to move her hand and grab things. It was reported that, for a couple of days, the patient felt pain in side where she got the shot and was not able to sleep on her left side. The patient stated that, 2 or 3 weeks after the flu shot, the pain in the arm had disappeared and she was able to sleep properly after 10 days of administration of vaccine. At the time of this report, the patient had recovered from the events. The reporter assessed the events as non-serious. Follow-up received on 13-Nov-2017: Added dose of suspect vaccine, route of administration and anatomical location. Added new event sleep unwell. The reporter stated that the events were still ongoing. The patient still felt pain in the side were she got the shot and has not been sleeping well lately. It was reported that she does not have pain as much as she had before but it has not gone away. The narrative was amended accordingly. Follow-up received on 05-Dec-2017: The onset date of the event sleep unwell was added. The outcome of the events was updated. The narrative was amended accordingly.
Case number PHEH2013US022536 is an initial spontaneous report received from a nurse on 24 Oct 2013: This report refers to patient of unknown age and gender. This patient was vaccinated with FLUVIRIN (batch number: 1308101 and expiry date: Mar 2014) on an undetermined date. The patient developed a red, raised and hot reaction around the injection site after vaccination. The reaction was between the size of a baseball, softball and soccer ball. SOLUMEDROL 40 mg shot was given that resolved the reaction. No further information about seriousness and causality was reported.
Information has been received from an office manager concerning some infant patients, patient's demographics were not available, who on unspecified dates were vaccinated with a dose of PNEUMOVAX 23 instead of giving them PREVNAR. No adverse effect was reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mention in this report. Additional information will be provided if available. Additional information has been requested.
I had two shots in March of 2021, and in April I thought I had Lyme disease again.  After several weeks of doxycycline, we stopped and tried to figure things out.  I would feel better with the. Steroid pack, but then would feel really bad again right after. In June I ended up in Hospital and thought it was because the Lyme meningitis- after basically be admitted into the hopsital. After the diagnosis, I started seeing a Rhemetholgist and he also agreed that is what I was dealing with. Dr has been treating ever since (about a little more than a year) I have come down from 40 milligrams to 4 mg.  My pain as subsided a lot, but after reviewing the facts I believe that it had to be the shot.
on 3/23 iI noticed a red circular area about the size of  quarter near my R pubic area  with a few red dots around my R shouler this rapidly progressed until it covered my entire body very red and angr I saw my PCP on  3/29 and he prescribed  prednisone and told me to see my dermatologist which I did the next day and prescribed zyrtec and a topical cream both physicians told me not to take the second shot
Flu like symptoms: chills, body ache, runny nose, cough, perioral rash.
COVID+ 11/19/2022  Vaccination status - Pfizer x2, moderna x1 BRIEF OVERVIEW: Discharge Provider: PRIVATE DO Primary Care Provider: PRIVATE MD Admission Date: 11/19/2022 Discharge Date: Nov 23, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/20/2022 Yes ? Foster care (status   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: 25-year-old male with cerebral palsy and developmental delay resides at PRIVATE. Pt. presented to the ED with concerns of a cough. He was found to have COVID and admitted to the hospital. Chest x-ray and labs were unremarkable. No treatment was initiated as patient's O2 sats were WNL on room air throughout his admission. Pt. will follow up with his PCP outpatient. He will return to his PRIVATE in improved and stable condition.   Attestation signed by PRIVATE, DO at 11/23/2022  5:09 PM   I have personally interviewed and examined the patient on 11/23/2022. Management was discussed. I agree with the documented findings and plan of care in his/her note.   Brief exam: Gen: Awake, NAD CV: RRR Lungs: CTAB Abd: Soft, ND/NT Ext: Contractures of LE bilaterally   Brief history and medical decision making:  Patient is a 25-year-old male with history as outlined below who presented to the emergency department with concerns of cough.  He was found to have COVID with chest x-ray and blood work unremarkable. Patient did not require treatment for COVID during his stay due to no hypoxia and minimal symptoms. Discharge was delayed due to ability to return to his PRIVATE, however patient was discharged back to home in stable condition on 11/23/2022.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 1:40 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 1:40 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 71.16 for dose administered on 12-Feb-2021.   No concomitant medications were reported.  Batch number 031L20A underwent temperature excursion on 12-Feb-2021 with temperature 29 degrees Fahrenheit at 09:00 AM and temperature 35 degrees Fahrenheit from 10:00 AM to 11:00 AM. This vial was moved to fridge on 09-Feb-2021and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 12-Feb-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Vaccines administered at 12 PM with 'some fussiness" x 5 hours crying continually and "not acting normal" from 5 pm till 11 PM slept for 8 hours from 11 PM till 7 AM (9-7-12) fed well patient was not examined for fussiness/crying episode.
Full blown varicella 03/01 after having vaccination on 10/30/00.
A 13 month old pt received the varicella vaccine on 3/7/00. The pt developed chicken pox lesions on 3/28/00 following vaccine (one on face and 2 on trunk). No fever, no other reaction.
Patient presented with significant rigors eight hours following vaccination. Received Acetaminophen, Ketorolac, and Diphenhydramine and was given warm blankets with resolution of symptoms within two hours.
was in hospital for 5 days; Two hours after the injection, his defibrillator (ICD) went off once; Initial information received on 09-Sep-2022 regarding an unsolicited valid serious case received from a patient's wife (non healthcare professional).  This case involves a elderly male patient who was in hospital for 5 days and two hours after the injection, his defibrillator (ICD) went off once, after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history included had a defibrillator (implantable defibrillator insertion). The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an  unknown date in 2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE, at dose of 0.7 ml once (1X) , wit an unknown formulation, strength, dose, batch number and expiry date , in unknown administration site. for immunization. Information on batch number has been requested.  On the same day in 2021, two hours after the injection, his defibrillator (ICD) went off once (device malfunction). His defibrillator never went off before that time. He had a defibrillator for years. He was in the hospital for 5 days afterwards (hospitalisation) (onset date: 2021; latency: few days) (seriousness criteria: hospitalization), and all the physicians told him that the event had nothing to do with his receipt of a flu shot. Patient is over 65 years old, so she (wife) believes he probably got a high dose shot, but she is not sure and did not have the exact name of it. She does know for sure that the flu vaccine was made by Sanofi, because she called the store from whom it was received, and they told him it was a Sanofi flu shot. She did not have the lot or expiry, but said she could find that out and either call back, or would put it on a questionnaire if she received one.   Action taken:  not applicable.  It was not reported if the patient received a corrective treatment for the events (Two hours after the injection, his defibrillator (ICD) went off once, was in hospital for 5 days).  Outcome: unknown for both the events; Sender's Comments: Sanofi company comment dated 16-Sep-2022: This case involves a elderly male patient who was in hospital for 5 days and two hours after the injection, his defibrillator (ICD) went off once, after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].. Case will be reevaluated post further update on concomitant medications, concurrent condition during vaccination, underlying disease, laboratory investigations excluding alternative etiologies for the reported event which will aid a comprehensive assessment of this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
sx-hot flashes, lightheaded, stiff tounge, watery mouth, nauseous  tx-rest